906079-28-5

Basic information

• Product Name: (S)-[3,4-dihydro-6-benzyloxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl]methyl trifluoromethane-sulfonate
• Synonyms: (S)-[3,4-dihydro-6-benzyloxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl]methyl trifluoromethane-sulfonate
• CAS NO: 906079-28-5
• Molecular Weight: 458.499
• Mol File: 906079-28-5.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: (S)-[3,4-dihydro-6-benzyloxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl]methyl trifluoromethane-sulfonate(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-[3,4-dihydro-6-benzyloxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl]methyl trifluoromethane-sulfonate(906079-28-5)
• EPA Substance Registry System: (S)-[3,4-dihydro-6-benzyloxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl]methyl trifluoromethane-sulfonate(906079-28-5)

Safety Data

• Hazardous Substances Data: 906079-28-5(Hazardous Substances Data)

Upstream product

• 53101-51-2 (-)-6-benzyloxy-2,5,7,8-tetramethylchromane-2-carboxylic acid 
• 210174-90-6 methyl-6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromene-2-carboxylate 
• 56305-04-5 trolox 
• 865444-18-4 4-(benzyloxy)-2,3,5-trimethyl-6-(3-methylbut-3-en-1-yl)phenol 
• 188416-12-8 (S)-4-((6-hydroxy-2,5,7,8-tetramethylchroman-2-yl)methoxy)-4-oxobutanoic acid 
• 79907-49-6 2-hydroxymethyl-2,5,7,8-tetramethyl-chroman-6-ol 
• 86646-83-5 methyl 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylate 
• 700-13-0 Trimethylhydroquinone 
• 53101-49-8 (S)-6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid 
• 100-39-0 benzyl bromide 
• 479353-37-2 Acetic acid (S)-6-hydroxy-2-hydroxymethyl-5,7,8-trimethyl-chroman-2-ylmethyl ester 
• 105857-77-0 2,2-Bis-hydroxymethyl-5,7,8-trimethyl-chroman-6-ol 
• 69427-83-4 (S)-(+)-6-hydroxy-2,5,7,8-tetramethylchroman-2-methanol 
• 358-23-6 trifluoromethylsulfonic anhydride 

Downstream Products

• 906079-30-9 (2S)-6-(benzyloxy)-2,5,7,8-tetramethyl-2-((3E,7E)-4,8,12-trimethyl-2-(phenylsulfonyl)trideca-3,7,11-trien-1-yl)chromane 
• 906079-31-0 (R)-6-(benzyloxy)-2,5,7,8-tetramethyl-2-((3E,7E)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl)chromane 
• 1721-51-3 alpha-tocotrienol 
• 78656-12-9 (2R,4’R,8’S)-α-tocopherol 
• 78656-13-0 (2R,4’S,8’R)-α-tocopherol 
• 59-02-9 Tocopherol 

Relevant articles and documents

CHINONE-, HYDROCHINOME- AND NAPHTHOCHINONE-ANALOGUES OF VATIQUIONE FOR TREATMENT OF MITOCHONDRIAL DISORDER DISEASES

The disclosure provides therapeutic compositions (i.e., therapeutic agents) and methods of preventing or treating Friedreich's ataxia in a mammalian subject, reducing risk factors, signs and/or symptoms associated with Friedreich's ataxia (e.g. Complex I deficiency), and/or reducing the likelihood or severity of Friedreich's ataxia. The disclosure further provides novel intermediates for the production of said therapeutic compositions and related reduced versions of said therapeutic compositions, which reduce forms may also be used as therapeutic agents (or prodrugs of the therapeutic agent(s)).

DEUTERATED EPI-743

This invention relates to novel α-tocotrienol quinones of Formula I: (I), and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treat

Chemoenzymatic synthesis of both enantiomers of α-tocotrienol

The stereoselective acylation of the achiral chromanedimethanol derivative 1 by vinyl acetate in the presence of Candida antarctica lipase B gave the (S)-monoester 2 in high enantiomeric purity (ee ≥ 98%). Enzymatic hydrolysis of diesters of compound 1 failed to give (R)-monoester 2 in good yield and high ee. Thus, both enantiomers of α-tocotrienol were synthesized from the (S)-monoester 2.